Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 2
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Aroori, Sree V. Cogan, Tristan A. and Humphrey, Tom J. 2014. Effect of Noradrenaline on the Virulence Properties ofCampylobacterSpecies. International Journal of Microbiology, Vol. 2014, p. 1.


    Howell, Rebecca J. Davolos, Alexandra G. Clary, Matthew S. Frake, Paul C. Joshi, Arjun S. and Chaboki, Houtan 2010. Miller fisher syndrome presents as an acute voice change to hypernasal speech. The Laryngoscope, p. NA.


    ×

Miller Fisher syndrome: a diagnosis not to be missed

  • S J Davis (a1), R Salib (a1), H Buchan (a2) and E Nilssen (a1)
  • DOI: http://dx.doi.org/10.1017/S0022215107005889
  • Published online: 01 March 2007
Abstract
Abstract

We report a case of Miller Fisher syndrome presenting in an ENT setting. The referral was made on the basis of worsening nasal regurgitation following Campylobacter jejuni enteritis. The aim of this report is not to add to the recorded instances of Miller Fisher syndrome, but to help raise the level of its awareness amongst otolaryngologists. Emphasis is placed on the mode of presentation and management issues, as early diagnosis is crucial and confers a favourable prognosis. In that respect, we consider this case noteworthy and instructive.

Copyright
Corresponding author
Address for correspondence: Mr S J Davis, 106 Nibley Road, Shirehampton, Bristol BS11 9XW, UK. Fax: 0117 9595850 E-mail: sd4166@hotmail.com
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1CM Fisher . An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:5765

2JR Overell , HJ Willison . Recent developments in Miller Fisher syndrome and related disorders. Curr Opin Neurol 2005;18:562–6

4A Chiba , S Kusunoki , H Obata , R Machinami , I Kanazawa . Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997;745:32–6

5N Yuki , T Taki , M Takahashi , K Saito , H Yoshino , T Tai Molecular mimicry between GQ1b, ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791–3

6M Koga , M Gilbert , J Li , S Koike , M Takahashi , K Furukawa Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005;64:1605–11

7CS Goodyear , GM O'Hanlon , JJ Plomp , ER Wagner , I Morrison , J Veitch Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 1999;104:697708

8SK Halstead , GM O'Hanlon , PD Humphreys , DB Morrison , BP Morgan , AJ Todd Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 2004;127:2109–23

9GM O'Hanlon , JJ Plomp , M Chakrabarti , I Morrison , ER Wagner , CS Goodyear Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001;124:893906

10RA Hughes , DR Cornblath . Guilain-Barre syndrome. Lancet 2005;366:1653–66

11JM Meythaler . Rehabilitation of Guillain-Barré syndrome. Arch Phys Med Rehabil 1997;78:872–9

12RJ Guiloff . Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1977;40:801–7

13RD Fross , J Daube . Neuropathy in the Miller-Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493–8

14F Battaglia . Recurrent Miller-Fisher syndrome. Rev Neurol (Paris) 2005;161:844–7

15The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096–104

16GM McKhann , JW Griffin , DR Cornblath , ED Mellits , RS Fisher , SA Quaskey . Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988;23:347–53

17French Cooperative Group on plasma exchange in Guillain-Barré syndrome. Appropriate number of plasma exchanges in Guillain-Barré syndrome. Ann Neurol 1997;41:298306

20RAC Hughes , E Wijdicks , RJ Barohn . Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;61:736–40

21MC Dalakas . Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 2004;291:2367–75

22R Korinthenberg , J Schessl , J Kirschner , JS Montning . Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome. Pediatrics 2005;116:226–8

23P Farcas , L Avnun , YO Herishanu , I Wirguin . Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome. Lancet 1997;350:1747

24HJ Willison , K Townson , J Veitch , J Boffrey , N Issacs , SM Andersen Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain 2004;127:680–91

, . . ;:CD00144625RAC Hughes FG van der Meche Corticosteroids for treating Guillain-Barré syndrome Cochrane Database Syst Rev 2000 2

26MM Rich , MJ Pinter , SD Craner , RL Barchi . Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998;43:171–9

27J Pritchard , IA Gray , ZR Idrissova , BR Lecky , IJ Sutton , AV Swan A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barré syndrome. Neurology 2003;61:1282–4

28DA Bechtold , X Yue , RM Evans , M Davies , NA Gregson , KJ Smith . Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 2005;128:1828

29IS Merkies , PI Schmitz , JP Samijn , FG van der Meché , PA van Doom . Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 1999;53:1648–54

30AJAM Bernsen , AEJ De Jager , PIM Schmitz , FGA van der Meché . Long-term impact on work and private life after Guillain-Barré syndrome. J Neurol Sci 2002;201:1317

31ER Bickerstaff , PC Cloake . Mesencephalitis and rhombencephalitis. BMJ 1951;2:7781

32M Odaka , N Yuki , M Yamada , M Koga , T Tagemi , K Hirata Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome. Brain 2003;126:2279–90

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: